塞来昔布诱发的胆汁淤积性肝衰竭，需进行原位肝移植。
Celecoxib-induced cholestatic liver failure requiring orthotopic liver transplantation.
作者信息
El Hajj Ihab I, Malik Shahid M, Alwakeel Hany R, Shaikh Obaid S, Sasatomi Eizaburo, Kandil Hossam M
机构信息
Department of Internal Medicine, Division of Gastroenterology, Hepatology and Nutrition, University of Pittsburgh Medical Center, Pittsburgh, PA 15213, United States.
出版信息
World J Gastroenterol. 2009 Aug 21;15(31):3937-9. doi: 10.3748/wjg.15.3937.
Abstract
Selective cyclooxygenase-2 (COX-2) inhibitors are widely used due to their efficacy and good safety profile. However, recent case reports have described varying degrees of liver injuries associated with the use of COX-2 inhibitors. We report the case of a patient who developed acute cholestatic hepatitis progressing to hepatic failure requiring liver transplantation, following a 3-d course of celecoxib for treatment of generalized muscle aches and pains. The clinical presentation, the laboratory data, as well as the liver histopathology were supportive of the putative diagnosis of drug induced liver injury.
摘要
选择性环氧化酶-2（COX-2）抑制剂因其疗效和良好的安全性而被广泛使用。然而，最近的病例报告描述了使用COX-2抑制剂相关的不同程度的肝损伤。我们报告了一例患者，在服用塞来昔布3天以治疗全身肌肉酸痛后，发生急性胆汁淤积性肝炎并进展为肝衰竭，需要进行肝移植。临床表现、实验室数据以及肝脏组织病理学均支持药物性肝损伤的推定诊断。
相似文献
1
Celecoxib-induced cholestatic liver failure requiring orthotopic liver transplantation.塞来昔布诱发的胆汁淤积性肝衰竭，需进行原位肝移植。
World J Gastroenterol. 2009 Aug 21;15(31):3937-9. doi: 10.3748/wjg.15.3937.
2
Acute cholestatic hepatitis associated with celecoxib.
Ann Pharmacother. 2002 Dec;36(12):1887-9. doi: 10.1345/aph.1C110.
3
Acute hepatocellular and cholestatic injury in a patient taking celecoxib.一名服用塞来昔布的患者出现急性肝细胞损伤和胆汁淤积性损伤。
Postgrad Med J. 2001 Aug;77(910):548-50. doi: 10.1136/pmj.77.910.548.
4
Prolonged cholestasis associated with short-term use of celecoxib.
Gastroenterol Clin Biol. 2005 Dec;29(12):1286-8. doi: 10.1016/s0399-8320(05)82223-7.
5
Comment: acute cholestatic hepatitis associated with celecoxib.评论：与塞来昔布相关的急性胆汁淤积性肝炎。
Ann Pharmacother. 2003 May;37(5):748; author reply 748-9. doi: 10.1345/aph.1C110a.
6
Probable celecoxib-induced hepatorenal syndrome.可能由塞来昔布引起的肝肾综合征。
Ann Pharmacother. 2012 Apr;46(4):610-1. doi: 10.1345/aph.1Q671. Epub 2012 Apr 3.
7
Hepatic disorders in patients treated with COX-2 selective inhibitors or nonselective NSAIDs: a case/noncase analysis of spontaneous reports.使用COX-2选择性抑制剂或非选择性非甾体抗炎药治疗的患者的肝脏疾病：自发报告的病例/非病例分析
Clin Ther. 2006 Aug;28(8):1123-1132. doi: 10.1016/j.clinthera.2006.08.014.
8
Chronic effects of celecoxib, a cyclooxygenase-2 inhibitor, cause enhanced alcohol-induced liver steatosis in rats.环氧化酶-2抑制剂塞来昔布的慢性作用会加剧酒精诱导的大鼠肝脏脂肪变性。
Inflammopharmacology. 2006 Mar;14(1-2):36-41. doi: 10.1007/s10787-006-1506-8.
9
Efficacy and safety of the selective cyclooxygenase-2 inhibitor celecoxib in the treatment of rheumatoid arthritis and osteoarthritis in Japan.在日本，选择性环氧化酶-2 抑制剂塞来昔布治疗类风湿关节炎和骨关节炎的疗效和安全性。
Digestion. 2011;83(1-2):108-23. doi: 10.1159/000318746. Epub 2010 Nov 1.
10
Celecoxib-induced cholestatic hepatotoxicity in a patient with cirrhosis.塞来昔布诱发肝硬化患者胆汁淤积性肝毒性。
Ann Intern Med. 2002 Jul 2;137(1):75. doi: 10.7326/0003-4819-137-1-200207020-00030.
引用本文的文献
1
Drug-induced Liver Injury Considered Steroid-resistant and Histologically Diagnosed with Vanishing Bile Duct Syndrome.药物性肝损伤，考虑为类固醇抵抗且组织学诊断为消失的胆管综合征。
Intern Med. 2024 Jun 15;63(12):1719-1723. doi: 10.2169/internalmedicine.2427-23. Epub 2023 Nov 13.
2
Selenocoxib-3, a novel anti-inflammatory therapeutic effectively resolves colitis.塞来昔布-3，一种新型抗炎疗法，可有效缓解结肠炎。
Mol Cell Biochem. 2023 Mar;478(3):621-636. doi: 10.1007/s11010-022-04532-y. Epub 2022 Aug 24.
3
Secondary Sclerosing Cholangitis: a Review of Recent Literature.继发性硬化性胆管炎：近期文献综述
Curr Gastroenterol Rep. 2017 Sep;19(9):44. doi: 10.1007/s11894-017-0583-8.
4
Integrating Drug's Mode of Action into Quantitative Structure-Activity Relationships for Improved Prediction of Drug-Induced Liver Injury.将药物作用模式整合到定量构效关系中以改进药物性肝损伤的预测
J Chem Inf Model. 2017 Apr 24;57(4):1000-1006. doi: 10.1021/acs.jcim.6b00719. Epub 2017 Apr 10.
5
Drug-Induced Liver Injury: Pattern Recognition and Future Directions.药物性肝损伤：模式识别与未来方向
Gut Liver. 2016 Jan;10(1):27-36. doi: 10.5009/gnl15114.
6
Cholestatic hepatitis with small duct injury associated with celecoxib.与塞来昔布相关的伴有小胆管损伤的胆汁淤积性肝炎。
Case Rep Med. 2013;2013:315479. doi: 10.1155/2013/315479. Epub 2013 Jun 5.
本文引用的文献
1
Liver transplantation for nonsteroidal anti-inflammatory drug-induced liver failure: nimesulide as the first implicated compound.非甾体抗炎药所致肝衰竭的肝移植：尼美舒利为首个相关化合物
Eur J Gastroenterol Hepatol. 2007 Nov;19(11):919-22. doi: 10.1097/MEG.0b013e3282eeb4cc.
2
Clinical pharmacology of celecoxib, a COX-2 selective inhibitor.环氧化酶-2选择性抑制剂塞来昔布的临床药理学
Expert Opin Pharmacother. 2007 Aug;8(11):1719-32. doi: 10.1517/14656566.8.11.1719.
3
Acute cholestatic hepatitis associated with long-term use of rofecoxib.与长期使用罗非昔布相关的急性胆汁淤积性肝炎。
Dig Dis Sci. 2004 Mar;49(3):459-61. doi: 10.1023/b:ddas.0000020503.92146.8b.
4
Hepatotoxicity induced by celecoxib and amlodipine.塞来昔布和氨氯地平引起的肝毒性。
Swiss Med Wkly. 2004 Apr 3;134(13-14):201. doi: 10.4414/smw.2004.10479.
5
Acute cholestatic hepatitis associated with celecoxib.
Ann Pharmacother. 2002 Dec;36(12):1887-9. doi: 10.1345/aph.1C110.
6
Celecoxib-induced cholestatic hepatotoxicity in a patient with cirrhosis.塞来昔布诱发肝硬化患者胆汁淤积性肝毒性。
Ann Intern Med. 2002 Jul 2;137(1):75. doi: 10.7326/0003-4819-137-1-200207020-00030.
7
Acute hepatocellular and cholestatic injury in a patient taking celecoxib.一名服用塞来昔布的患者出现急性肝细胞损伤和胆汁淤积性损伤。
Postgrad Med J. 2001 Aug;77(910):548-50. doi: 10.1136/pmj.77.910.548.
8
Drug Points: Cholestatic hepatitis in association with celecoxib.药物要点：与塞来昔布相关的胆汁淤积性肝炎。
BMJ. 2001 Jul 7;323(7303):23. doi: 10.1136/bmj.323.7303.23.
9
Celecoxib-induced cholestatic hepatitis.塞来昔布诱导的胆汁淤积性肝炎。
Ann Intern Med. 2001 Feb 6;134(3):254. doi: 10.7326/0003-4819-134-3-200102060-00028.
10
Fatal hepatitis associated with nimesulide.与尼美舒利相关的致命性肝炎。
J Hepatol. 2000 Jan;32(1):174. doi: 10.1016/s0168-8278(00)80208-1.
Zotero 插件